SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-012551
Filing Date
2023-05-04
Accepted
2023-05-04 16:00:35
Documents
42
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20230331_10q.htm   iXBRL 10-Q 368941
2 EXHIBIT 10.3 ex_510145.htm EX-10.3 58862
3 EXHIBIT 31.1 ex_510146.htm EX-31.1 12355
4 EXHIBIT 31.2 ex_510147.htm EX-31.2 12354
5 EXHIBIT 32.1 ex_510148.htm EX-32.1 4289
6 EXHIBIT 32.2 ex_510149.htm EX-32.2 4279
  Complete submission text file 0001437749-23-012551.txt   2061108

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA govx-20230331.xsd EX-101.SCH 22605
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20230331_def.xml EX-101.DEF 138510
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20230331_lab.xml EX-101.LAB 136337
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20230331_pre.xml EX-101.PRE 152780
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20230331_cal.xml EX-101.CAL 24657
36 EXTRACTED XBRL INSTANCE DOCUMENT govx20230331_10q_htm.xml XML 156282
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 23888440
SIC: 2834 Pharmaceutical Preparations